Site Members can sign up for company wide alerts
Investigation Overview
August 27, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) was announced concerning whether certain ImmunoCellular Therapeutics officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether c...
You must register (for free) or login to view the entire investigation.